Divalproex Sodium Tablet, Film Coated, Extended Release
Product Images NDC 72162-2515

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Divalproex Sodium (NDC 72162-2515). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Bryant Ranch Prepack, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Figure 1 (Divalproex Fig1)

A clinical efficacy figure plotting percentage of patients on the horizontal axis against percent reduction in CPS rate on the vertical axis. The graph compares Divalproex Sodium Delayed-Release Tablets to placebo, showing trends of improvement versus worsening in patients.*

FDA Label Image

Figure 2 (Divalproex Fig2)

A cumulative distribution plot showing percentage reduction in CPS rate on the vertical axis and percentage of patients on the horizontal axis, comparing high dose versus low dose divalproex sodium delayed-release tablets. The graph illustrates patient response variability, indicating change from worsening to improvement across doses.*

FDA Label Image

Figure-3 (Divalproex Fig3)

A bar chart comparing the effect of placebo and Divalproex Sodium Extended-Release Tablets. The vertical axis represents a measurement scale from 0 to 1.2, with the bar for placebo at 0.6 and the bar for Divalproex Sodium Extended-Release Tablets reaching 1.2. The comparison includes a significance marker indicating p=0.006.*

FDA Label Image

Structure (Divalproex Str)

Chemical structure of divalproex sodium shown as a polymeric repeating unit with sodium and carboxylate groups, illustrating the extended molecular arrangement of the active ingredient.*

FDA Label Image

Label (Lbl721622515)

Label for Divalproex Sodium Extended-Release Tablets USP 250 mg. The label shows the NDC 72162-2515-1 and indicates the package contains 100 film-coated extended-release oral tablets. The labeler is Bryant Ranch Prepack and the manufacturer is Aurobindo Pharma Limited. Storage instructions and QR codes for the medication guide and prescribing information are also included.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.